|
NFKB1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.200000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.052200E-01 |
| Normal-vs-Stage2 |
5.115400E-01 |
| Normal-vs-Stage3 |
8.185800E-01 |
| Normal-vs-Stage4 |
4.914400E-01 |
| Stage1-vs-Stage2 |
7.742400E-01 |
| Stage1-vs-Stage3 |
5.874600E-01 |
| Stage1-vs-Stage4 |
3.394800E-01 |
| Stage2-vs-Stage3 |
4.653400E-01 |
| Stage2-vs-Stage4 |
2.766800E-01 |
| Stage3-vs-Stage4 |
5.495400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.885800E-01 |
| Normal-vs-AfricanAmerican |
3.435400E-01 |
| Normal-vs-Asian |
2.203400E-01 |
| Caucasian-vs-AfricanAmerican |
7.777000E-01 |
| Caucasian-vs-Asian |
3.278200E-01 |
| AfricanAmerican-vs-Asian |
2.453600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.850400E-01 |
| Normal-vs-Female |
1.144620E-01 |
| Male-vs-Female |
1.515440E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.543800E-01 |
| Normal-vs-Extreme_Weight |
8.039600E-01 |
| Normal-vs-Obese |
2.189800E-01 |
| Normal-vs-Extreme_Obese |
9.349400E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.359800E-01 |
| Normal_Weight-vs-Obese |
1.237750E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.138000E-01 |
| Extreme_Weight-vs-Obese |
3.151600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.436400E-01 |
| Obese-vs-Extreme_Obese |
5.059000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.655000E-01 |
| Normal-vs-Age(41-60Yrs) |
9.962000E-02 |
| Normal-vs-Age(61-80Yrs) |
8.015800E-01 |
| Normal-vs-Age(81-100Yrs) |
6.634600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.816800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.944000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.821200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.162030E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.964000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.484200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.620200E-02 |
| Normal-VS-Type2 PRCC |
2.593800E-01 |
| Normal-VS-KIRP CIMP |
3.652300E-02 |
| Normal-VS-Unclassified PRCC |
5.398400E-02 |
| Type1 PRCC-VS-Type2 PRCC |
3.002700E-03 |
| Type1 PRCC-VS-KIRP CIMP |
4.638100E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.365000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.107200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.097700E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
2.782500E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.022000E-01 |
| Normal-vs-N1 |
9.776400E-01 |
| Normal-vs-N2 |
7.985800E-02 |
| N0-vs-N1 |
5.886000E-01 |
| N0-vs-N2 |
3.631200E-01 |
| N1-vs-N2 |
5.624300E-02 |
|
|
